CD274 and neoplasm: Consequently, first-line checkpoint inhibitors have been approved to replace chemotherapy in the form of monotherapy for patients with high PD-L1 expression on tumor cells or in the form of combination with chemotherapy regardless of PD-L1 expression 2-9.